Departamento de Biomedicina Cardiovascular.
Unidad de Cuidados Coronarios, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Liver Transpl. 2018 Aug;24(8):1070-1083. doi: 10.1002/lt.25179.
Cytidine-5'-diphosphocholine (CDP-choline) participates as an intermediary in the synthesis of phosphatidylcholine, an essential component of cellular membranes. Citicoline treatment has shown beneficial effects in cerebral ischemia, but its potential to diminish reperfusion damage in liver has not been explored. In this work, we evaluated the hepatoprotective effect of citicoline and its possible association with inflammatory/oxidative stress and mitochondrial function because they are the main cellular features of reperfusion damage. Ischemia/reperfusion (I/R) in rat livers was performed with the Pringle's maneuver, clamping the 3 elements of the pedicle (hepatic artery, portal vein, and biliary tract) for 30 minutes and then removing the clamp to allow hepatic reperfusion for 60 minutes. The I/R + citicoline group received the compound before I/R. Liver injury was evaluated by measuring aspartate aminotransferase and alanine aminotransferase as well as lactic acid levels in serum; proinflammatory cytokines, proresolving lipid mediators, and nuclear factor kappa B content were determined as indicators of the inflammatory response. Antioxidant effects were evaluated by measuring markers of oxidative stress and antioxidant molecules. Oxygen consumption and the activities of the respiratory chain were used to monitor mitochondrial function. CDP-choline reduced aspartate aminotransferase (AST), alanine aminotransferase (ALT), as well as lactic acid levels in blood samples from reperfused rats. Diminution in tumor necrosis factor alpha (TNF-α) and increase in the proresolving lipid mediator resolvin D1 were also observed in the I/R+citicoline group, in comparison with the I/R group. Oxidative/nitroxidative stress in hepatic mitochondria concurred with deregulation of oxidative phosphorylation, which was associated with the loss of complex III and complex IV activities. In conclusion, CDP-choline attenuates liver damage caused by ischemia and reperfusion by reducing oxidative stress and maintaining mitochondrial function. Liver Transplantation XX XX-XX 2018 AASLD.
胞苷二磷酸胆碱(CDP-胆碱)作为合成磷脂酰胆碱的中间产物,是细胞膜的重要组成部分。胞磷胆碱治疗已显示出在脑缺血中的有益作用,但它是否能减轻肝脏再灌注损伤尚未得到探索。在这项工作中,我们评估了胞磷胆碱的肝保护作用及其与炎症/氧化应激和线粒体功能的可能关联,因为它们是再灌注损伤的主要细胞特征。通过普雷格尔(Pringle)手法对大鼠肝脏进行缺血/再灌注(I/R),夹闭肝蒂的 3 个部分(肝动脉、门静脉和胆管)30 分钟,然后去除夹闭以允许肝脏再灌注 60 分钟。I/R+胞磷胆碱组在 I/R 前给予该化合物。通过测量血清中天冬氨酸转氨酶和丙氨酸转氨酶以及乳酸水平来评估肝损伤;通过测定促炎细胞因子、促修复脂质介质和核因子κB 含量来确定炎症反应的指标。通过测定氧化应激和抗氧化分子的标志物来评估抗氧化作用。通过监测耗氧量和呼吸链的活性来监测线粒体功能。CDP-胆碱可降低再灌注大鼠血样中的天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和乳酸水平。与 I/R 组相比,I/R+胞磷胆碱组也观察到肿瘤坏死因子-α(TNF-α)减少和促修复脂质介质 17 型 resolvin D1 增加。肝线粒体的氧化/硝化应激与氧化磷酸化的失调相一致,这与复合物 III 和复合物 IV 活性的丧失有关。总之,CDP-胆碱通过降低氧化应激和维持线粒体功能来减轻缺血再灌注引起的肝损伤。肝移植 XX XX-XX 2018 AASLD。